Palantir Q1 2026 Earnings EPS Surpasses Estimates Revenue Details Unavailable Stock Edges Lower NRX Pharmaceuticals Q1 2026 Earnings EPS Miss Marks 114 Surprise Shortfall Stock Surges 20 FIS Q1 2026 Earnings EPS Surpasses Estimates by 464 as Stock Moves Lower GXAI Q1 2026 Earnings EPS Misses Estimates by 1765 Stock Declines Coherent Corp Q1 2026 Earnings EPS Slightly Misses Consensus Stock Edges Up NeuroOne Medical Technologies NMTC Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Continues to Invest in Development